CA Stock MarketDetailed Quotes

Imagin Medical Inc (IME)

Watchlist
  • 0.015
  • 0.0000.00%
15min DelayMarket Closed Apr 12 09:30 ET
162.45KMarket Cap-0.04P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Imagin Medical Inc (IME) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
(Q1)Dec 31, 2022
(FY)Sep 30, 2022
(Q4)Sep 30, 2022
(Q3)Jun 30, 2022
(Q2)Mar 31, 2022
(Q1)Dec 31, 2021
(FY)Sep 30, 2021
(Q4)Sep 30, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
102.59%17.6K
40.49%-484.33K
71.90%-231.69K
35.83%-2.63M
76.93%-308.56K
26.65%-680.2K
5.82%-813.91K
14.55%-824.55K
0.44%-4.09M
-453.65%-1.34M
Net income from continuing operations
-52.61%2.2M
23.95%-873.27K
101.21%15.99K
78.28%-2.49M
42.82%-4.67M
1,168.64%4.65M
50.35%-1.15M
-135.21%-1.32M
-162.14%-11.47M
-1,084.74%-8.16M
Depreciation and amortization
505.62%46.33K
505.62%46.33K
505.62%46.33K
60.38%47.13K
100.48%24.18K
190.65%7.65K
4.14%7.65K
4.12%7.65K
-8.67%29.39K
-18.79%12.06K
Remuneration paid in stock
-87.74%8.82K
--8.82K
--8.82K
6.09%96.11K
269,077.78%24.23K
389.80%71.89K
--0
--0
166.94%90.6K
--9
Other non cashItems
53.55%-2.56M
39.55%509.14K
-228.06%-686.08K
-113.78%-1.04M
-47.80%3.57M
-880.72%-5.51M
-73.76%364.84K
577.29%535.76K
--7.56M
--6.84M
Change In working capital
203.03%320.82K
-359.97%-175.36K
942.87%383.26K
358.09%763.09K
3,043.83%740.82K
102.96%105.87K
-53.28%-38.12K
84.73%-45.47K
-248.77%-295.66K
-105.82%-25.17K
-Change in receivables
-92.22%14.98K
125.40%8.08K
-41.46%9.54K
170.85%240.62K
170.83%63.64K
642.29%192.48K
24.39%-31.81K
104.70%16.3K
-1,195.98%-339.62K
-32.58%23.5K
-Change in payables and accrued expense
453.14%305.84K
-2,803.34%-183.43K
704.98%373.72K
1,088.60%522.47K
1,491.49%677.17K
-430.14%-86.61K
-136.74%-6.32K
-225.57%-61.77K
-73.80%43.96K
-112.23%-48.67K
Cash from discontinued investing activities
Operating cash flow
102.59%17.6K
40.49%-484.33K
71.90%-231.69K
35.83%-2.63M
76.93%-308.56K
26.65%-680.2K
5.82%-813.91K
14.55%-824.55K
0.44%-4.09M
-453.65%-1.34M
Investing cash flow
Cash flow from continuing investing activities
0
0
1,358.54%86.02K
-11,321.19%-780.64K
-773.8K
0
0
-6.84K
79.38%-6.84K
0
Net intangibles purchas and sale
--0
--0
1,358.54%86.02K
-11,321.19%-780.64K
---773.8K
--0
--0
---6.84K
79.38%-6.84K
--0
Cash from discontinued investing activities
Investing cash flow
--0
--0
1,358.54%86.02K
-11,321.19%-780.64K
---773.8K
--0
--0
---6.84K
79.38%-6.84K
--0
Financing cash flow
Cash flow from continuing financing activities
0
-71.43%455.11K
-77.28%139.14K
-26.65%3.18M
11.51%977.02K
0
-11.87%1.59M
-38.26%612.39K
128.37%4.34M
1,652.41%876.21K
Net issuance payments of debt
--0
-71.43%455.11K
-76.76%139.14K
-34.63%2.84M
-26.44%644.52K
--0
-11.87%1.59M
-39.64%598.68K
--4.34M
--876.21K
Net common stock issuance
--0
--0
--0
--13.71K
--0
--0
--0
--13.71K
--0
----
Net other financing activities
----
----
----
--332.5K
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
--0
-71.43%455.11K
-77.28%139.14K
-26.65%3.18M
11.51%977.02K
--0
-11.87%1.59M
-38.26%612.39K
128.37%4.34M
1,652.41%876.21K
Net cash flow
Beginning cash position
-99.45%4.57K
-27.60%33.79K
-84.82%40.32K
861.92%265.66K
-79.96%145.67K
-17.82%825.87K
-14.32%46.67K
861.92%265.66K
-98.78%27.62K
170.06%727.01K
Current changes in cash
102.59%17.6K
-103.75%-29.22K
97.02%-6.53K
-194.66%-225.34K
77.17%-105.34K
-144.76%-680.2K
-18.02%779.2K
-915.40%-218.99K
110.60%238.05K
-90.97%-461.35K
End cash Position
-84.78%22.17K
-99.45%4.57K
-27.60%33.79K
-84.82%40.32K
-84.82%40.32K
-79.96%145.67K
-17.82%825.87K
-14.32%46.67K
861.92%265.66K
861.92%265.66K
Free cash from
102.59%17.6K
40.49%-484.33K
72.13%-231.69K
16.90%-3.41M
19.08%-1.08M
26.65%-680.2K
6.56%-813.91K
13.84%-831.38K
1.07%-4.1M
-453.65%-1.34M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Jun 30, 2023(Q2)Mar 31, 2023(Q1)Dec 31, 2022(FY)Sep 30, 2022(Q4)Sep 30, 2022(Q3)Jun 30, 2022(Q2)Mar 31, 2022(Q1)Dec 31, 2021(FY)Sep 30, 2021(Q4)Sep 30, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 102.59%17.6K40.49%-484.33K71.90%-231.69K35.83%-2.63M76.93%-308.56K26.65%-680.2K5.82%-813.91K14.55%-824.55K0.44%-4.09M-453.65%-1.34M
Net income from continuing operations -52.61%2.2M23.95%-873.27K101.21%15.99K78.28%-2.49M42.82%-4.67M1,168.64%4.65M50.35%-1.15M-135.21%-1.32M-162.14%-11.47M-1,084.74%-8.16M
Depreciation and amortization 505.62%46.33K505.62%46.33K505.62%46.33K60.38%47.13K100.48%24.18K190.65%7.65K4.14%7.65K4.12%7.65K-8.67%29.39K-18.79%12.06K
Remuneration paid in stock -87.74%8.82K--8.82K--8.82K6.09%96.11K269,077.78%24.23K389.80%71.89K--0--0166.94%90.6K--9
Other non cashItems 53.55%-2.56M39.55%509.14K-228.06%-686.08K-113.78%-1.04M-47.80%3.57M-880.72%-5.51M-73.76%364.84K577.29%535.76K--7.56M--6.84M
Change In working capital 203.03%320.82K-359.97%-175.36K942.87%383.26K358.09%763.09K3,043.83%740.82K102.96%105.87K-53.28%-38.12K84.73%-45.47K-248.77%-295.66K-105.82%-25.17K
-Change in receivables -92.22%14.98K125.40%8.08K-41.46%9.54K170.85%240.62K170.83%63.64K642.29%192.48K24.39%-31.81K104.70%16.3K-1,195.98%-339.62K-32.58%23.5K
-Change in payables and accrued expense 453.14%305.84K-2,803.34%-183.43K704.98%373.72K1,088.60%522.47K1,491.49%677.17K-430.14%-86.61K-136.74%-6.32K-225.57%-61.77K-73.80%43.96K-112.23%-48.67K
Cash from discontinued investing activities
Operating cash flow 102.59%17.6K40.49%-484.33K71.90%-231.69K35.83%-2.63M76.93%-308.56K26.65%-680.2K5.82%-813.91K14.55%-824.55K0.44%-4.09M-453.65%-1.34M
Investing cash flow
Cash flow from continuing investing activities 001,358.54%86.02K-11,321.19%-780.64K-773.8K00-6.84K79.38%-6.84K0
Net intangibles purchas and sale --0--01,358.54%86.02K-11,321.19%-780.64K---773.8K--0--0---6.84K79.38%-6.84K--0
Cash from discontinued investing activities
Investing cash flow --0--01,358.54%86.02K-11,321.19%-780.64K---773.8K--0--0---6.84K79.38%-6.84K--0
Financing cash flow
Cash flow from continuing financing activities 0-71.43%455.11K-77.28%139.14K-26.65%3.18M11.51%977.02K0-11.87%1.59M-38.26%612.39K128.37%4.34M1,652.41%876.21K
Net issuance payments of debt --0-71.43%455.11K-76.76%139.14K-34.63%2.84M-26.44%644.52K--0-11.87%1.59M-39.64%598.68K--4.34M--876.21K
Net common stock issuance --0--0--0--13.71K--0--0--0--13.71K--0----
Net other financing activities --------------332.5K------------------------
Cash from discontinued financing activities
Financing cash flow --0-71.43%455.11K-77.28%139.14K-26.65%3.18M11.51%977.02K--0-11.87%1.59M-38.26%612.39K128.37%4.34M1,652.41%876.21K
Net cash flow
Beginning cash position -99.45%4.57K-27.60%33.79K-84.82%40.32K861.92%265.66K-79.96%145.67K-17.82%825.87K-14.32%46.67K861.92%265.66K-98.78%27.62K170.06%727.01K
Current changes in cash 102.59%17.6K-103.75%-29.22K97.02%-6.53K-194.66%-225.34K77.17%-105.34K-144.76%-680.2K-18.02%779.2K-915.40%-218.99K110.60%238.05K-90.97%-461.35K
End cash Position -84.78%22.17K-99.45%4.57K-27.60%33.79K-84.82%40.32K-84.82%40.32K-79.96%145.67K-17.82%825.87K-14.32%46.67K861.92%265.66K861.92%265.66K
Free cash from 102.59%17.6K40.49%-484.33K72.13%-231.69K16.90%-3.41M19.08%-1.08M26.65%-680.2K6.56%-813.91K13.84%-831.38K1.07%-4.1M-453.65%-1.34M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.85%
Sample Name
Sample Code
 +16.38%
Sample Name
Sample Code
 +13.45%
4
BIDU-SW
09888
+5.97%
5
JD HEALTH
06618
+5.25%
View More
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -